Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function
- PMID: 12551928
- DOI: 10.1074/jbc.M208641200
Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function
Abstract
The accumulation of aggregated alpha-synuclein is thought to contribute to the pathophysiology of Parkinson's disease, but the mechanism of toxicity is poorly understood. Recent studies suggest that aggregated proteins cause toxicity by inhibiting the ubiquitin-dependent proteasomal system. In the present study, we explore how alpha-synuclein interacts with the proteasome. The proteasome exists as a 26 S and a 20 S species. The 26 S proteasome is composed of the 19 S cap and the 20 S core. Aggregated alpha-synuclein strongly inhibited the function of the 26 S proteasome. The IC(50) of aggregated alpha-synuclein for ubiquitin-independent 26 S proteasomal activity was 1 nm. Aggregated alpha-synuclein also inhibited 26 S ubiquitin-dependent proteasomal activity at a dose of 500 nm. In contrast, the IC(50) of aggregated alpha-synuclein for 20 S proteasomal activity was > 1 microm. This suggests that aggregated alpha-synuclein selectively interacts with the 19 S cap. Monomeric alpha-synuclein also inhibited proteasomal activity but with lower affinity and less potency. Recombinant monomeric alpha-synuclein inhibited the activity of the 20 S proteasomal core with an IC(50) > 10 microm, exhibited no inhibition of 26 S ubiquitin-dependent proteasomal activity at doses up to 5 microm, and exhibited only partial inhibition (50%) of the 26 S ubiquitin-independent proteasomal activity at doses up to 10 mm. Binding studies demonstrate that both aggregated and monomeric alpha-synuclein selectively bind to the proteasomal protein S6', a subunit of the 19 S cap. These studies suggest that proteasomal inhibition by aggregated alpha-synuclein could be mediated by interaction with S6'.
Similar articles
-
beta-Synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein.J Biol Chem. 2005 Mar 4;280(9):7562-9. doi: 10.1074/jbc.M412887200. Epub 2004 Dec 9. J Biol Chem. 2005. PMID: 15591046
-
alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.FEBS Lett. 2001 Nov 30;509(1):22-6. doi: 10.1016/s0014-5793(01)03115-5. FEBS Lett. 2001. PMID: 11734199
-
Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.Neuron. 2002 Dec 19;36(6):1007-19. doi: 10.1016/s0896-6273(02)01125-x. Neuron. 2002. PMID: 12495618
-
Pathological proteins in Parkinson's disease: focus on the proteasome.J Mol Neurosci. 2004;24(3):425-42. doi: 10.1385/JMN:24:3:425. J Mol Neurosci. 2004. PMID: 15655264 Review.
-
[Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].J Soc Biol. 2002;196(1):95-10. J Soc Biol. 2002. PMID: 12134640 Review. French.
Cited by
-
alpha-Synuclein and neuronal cell death.Mol Neurodegener. 2009 Feb 4;4:9. doi: 10.1186/1750-1326-4-9. Mol Neurodegener. 2009. PMID: 19193223 Free PMC article.
-
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies.J Neurosci. 2014 Jan 8;34(2):418-33. doi: 10.1523/JNEUROSCI.2712-13.2014. J Neurosci. 2014. PMID: 24403142 Free PMC article.
-
Targeting heat shock proteins to modulate α-synuclein toxicity.Ther Adv Neurol Disord. 2014 Jan;7(1):33-51. doi: 10.1177/1756285613493469. Ther Adv Neurol Disord. 2014. PMID: 24409201 Free PMC article. Review.
-
Microglial NLRP3 Inflammasome Activation upon TLR2 and TLR5 Ligation by Distinct α-Synuclein Assemblies.J Immunol. 2021 Oct 15;207(8):2143-2154. doi: 10.4049/jimmunol.2100035. Epub 2021 Sep 10. J Immunol. 2021. PMID: 34507948 Free PMC article.
-
T-Type Ca2+ Enhancer SAK3 Activates CaMKII and Proteasome Activities in Lewy Body Dementia Mice Model.Int J Mol Sci. 2021 Jun 8;22(12):6185. doi: 10.3390/ijms22126185. Int J Mol Sci. 2021. PMID: 34201181 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous